Prognostic Factors for Post-Transplant Outcomes in Patients with Myelodysplastic Syndromes (MDS)

被引：0
|
作者：
Bejanyan, Nelli [1 ]
Maciejewski, Jaroslaw P. [1 ]
Rybicki, Lisa [1 ]
O'Keefe, Christine L.
Nyatanga, Nolyn [1 ]
Tench, Shawnda [1 ]
Sekeres, Mikkael A. [1 ]
Advani, Anjali S. [1 ]
Saunthararajah, Yogen [1 ]
Duong, Hien [1 ]
Sobecks, Ronald [1 ]
Kalaycio, Matt [1 ]
Bolwell, Brian J. [1 ]
Copelan, Edward A. [1 ]
机构：
[1] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：881 / 881
页数：1
相关论文
共 50 条
  • [1] PROGNOSTIC FACTORS IN MYELODYSPLASTIC SYNDROMES (MDS)
    TRICOT, G
    VLIETINCK, R
    HENDRICKX, B
    VERWILGHEN, RL
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1985, 60 (02) : 362 - 362
  • [2] Impact of azacytidine induction chemotherapies on post-transplant outcomes in patients with myelodysplastic syndromes
    Cogle, C. R.
    Imanirad, I.
    Scornik, J.
    Wingard, J. R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [3] Impact of pretransplant neutropenia on post-transplant outcome in patients with Myelodysplastic syndrome (MDS).
    Scott, Bart L.
    Park, J. Y.
    Storer, B.
    Marr, K. A.
    Boeclch, M.
    Deeg, H. Joachim
    [J]. BLOOD, 2006, 108 (11) : 181A - 181A
  • [4] Does marrow fibrosis influence post-transplant outcome in patients with myelodysplastic syndrome (MDS)?
    Scott, BL
    Chyou, F
    Deeg, HJ
    [J]. EXPERIMENTAL HEMATOLOGY, 2004, 32 (07) : 47 - 48
  • [5] PROGNOSTIC FACTORS IN THE TRANSPLANT OF HEMATOPOIETIC PROGENITORS IN MYELODYSPLASTIC SYNDROMES
    Vico Herrera, I
    Alvarez Sanchez, A., I
    Manolo Yebenes, R.
    Carmen Martin, C.
    Sanchez Garcia, J.
    Serrano Lopez, J.
    Javier Casano, S.
    [J]. HAEMATOLOGICA, 2017, 102 : 271 - 271
  • [6] A post-transplant optimized transplant-specific risk score in myelodysplastic syndromes
    Gooptu, Mahasweta
    Koreth, John
    [J]. HAEMATOLOGICA, 2019, 104 (05) : 859 - 861
  • [7] Outcomes and prognostic factors for adult patients with Post-Transplant Lymphoproliferative Disorders: the Thames Valley experience
    Barbanti, Maria Chiara
    Burton, Kieran
    Fordwor, Katrina
    Pervaiz, Omer
    Sangha, Gavinda
    Stanton, Louise
    Collins, Graham
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 : 107 - 108
  • [8] Evaluating Stem Cells to Predict Post-Transplant Relapse in the Myelodysplastic Syndromes
    Kroger, Benjamin
    Huang, Yi
    Patel, Prapti
    Afrough, Aimaz
    Kaur, Gurbakhash
    Anderson, Larry D.
    Awan, Farrukh T.
    Ramakrishnan, Praveen
    Verma, Kunal
    Vittrup, Russell
    Collins, Robert H.
    Vusirikala, Madhuri
    Madanat, Yazan F.
    Tamari, Roni
    Chung, Stephen S.
    [J]. BLOOD, 2022, 140 : 9833 - 9835
  • [9] Model Heterogeneity in Predicting Outcomes of Patients with Myelodysplastic Syndromes (MDS)
    Al-Issa, Karam
    Madanat, Yazan F.
    Mukherjee, Sudipto
    Hirsch, Cassandra M.
    Gerds, Aaron T.
    Abuhadra, Nour
    Makhoul, Ahed
    Awada, Hassan
    Asad, Mohammad Fahad B.
    Goyal, Abhinav
    Advani, Anjali S.
    Kuzmanovic, Teodora
    Przychodzen, Bartlomiej P.
    Carraway, Hetty E.
    Maciejewski, Jaroslaw P.
    Sekeres, Mikkael A.
    Nazha, Aziz
    [J]. BLOOD, 2017, 130
  • [10] A Novel Prognostic Model in Heavily Treated Patients with Myelodysplastic Syndromes (MDS)
    Nazha, Aziz
    Seastone, David J.
    Radivoyevitch, Tomas
    Gerds, Aaron T.
    Mukherjee, Sudipto
    Carraway, Hetty E.
    Advani, Anjali S.
    Kalaycio, Matt E.
    Rupp, Gina
    Colaluka, Kristin
    Hobson, Sean
    Maciejewski, Jaroslaw P.
    Sekeres, Mikkael A.
    [J]. BLOOD, 2014, 124 (21)
12345